MOFFITT CANCER CENTER M

WIPO WIPO 2014

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark MOFFITT CANCER CENTER M was filed as Figurative mark on 06/23/2014 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Circles #Letters presenting a special form of writing #Circles containing one or more letters #Series of letters in different dimensions

Trademark Details Last update: February 19, 2020

Trademark form Figurative mark
File reference 1225217
Register number 3671302
Countries India
Base trademark US No. 3671302, August 25, 2009
Application date June 23, 2014
Expiration date June 23, 2024

Trademark owner

12902 Magnolia Drive
Tampa FL 336129497
US

Trademark representatives

P.O. Box 142950 Gainesville, FL 32614 US

goods and services

16 Publications, namely, printed instructional and teaching materials, brochures, pamphlets, bulletins, newsletters and magazines, all in the field of health care, cancer protection, prevention, detection and treatment, medical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases
41 Medical educational services, namely, conducting lectures, seminars and workshops to health care practitioners, patients and patient caregivers in the field of health care, cancer care and prevention of cancer, and medical diagnostics, prognostics and the evaluation of drug and treatment effectiveness relating to cancer and other diseases
42 Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicians, patients and researchers, namely, an online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing data regarding tumor-specific molecular signatures and the effectiveness of a drug and/or diagnostic test for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes for research purposes; medical research services consisting of collection and analysis of data in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, matching particular patients to a particular drug, treatment, therapy or clinical trial by the specific molecular signature of the patient; collection and analysis of data services in the field of human clinical and molecular data accumulation and analysis for research assistance for medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, providing objective data in usable form on the effectiveness of a drug or diagnostic test
44 Providing health care, medical information and counseling in the field of cancer; providing medical screening and diagnostic services with use of patient scanning equipment; providing an online computer database featuring medical information in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; medical services, namely, cancer care and prevention of cancer, and medical diagnostics, prognostics and evaluation of drug and treatment effectiveness relating to cancer and other diseases; medical counseling; telephone hot line counseling, namely, offering advice regarding cancer prevention, detection, treatment and clinical testing in the field of cancer and other diseases

Trademark history

Date Document number Area Entry
February 17, 2020 2020/8 Gaz IN Rejection
February 8, 2016 2016/8 Gaz IN Rejection
June 23, 2014 2014/47 Gaz US Registration

ID: 141225217